Congenital neutropenia occurs when an individual has low levels of neutrophils, a type of white blood cells. Neutrophils are made in the bone marrow, which is the spongy tissue found in larger bones such as the vertebrae, ribs, and pelvis. The congenital neutropenia treatment include antibiotics, antifungal drugs and so on.
This report contains market size and forecasts of Congenital Neutropenia Treatment in Global, including the following market information:
Global Congenital Neutropenia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Congenital Neutropenia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Congenital Neutropenia Treatment include Baxter International, Teva Pharmaceutical, Inc., Amgen, Sanofi, Novartis AG, Teva Pharmaceuticals Industries Ltd., Biogenomics Limited, Dr. Reddy’s Laboratory Ltd. and Apotex and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Congenital Neutropenia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Congenital Neutropenia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Congenital Neutropenia Treatment Market Segment Percentages, by Type, 2021 (%)
Antibiotics
Granulocyte -Colony- Stimulating Factor (G-CSF)
Antifungal Drugs
Global Congenital Neutropenia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Congenital Neutropenia Treatment Market Segment Percentages, by Application, 2021 (%)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Others
Global Congenital Neutropenia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Congenital Neutropenia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Congenital Neutropenia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Congenital Neutropenia Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter International
Teva Pharmaceutical, Inc.
Amgen
Sanofi
Novartis AG
Teva Pharmaceuticals Industries Ltd.
Biogenomics Limited
Dr. Reddy’s Laboratory Ltd.
Apotex
Intas Pharmaceuticals Ltd.